{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:11:44Z","timestamp":1783977104394,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07086-x","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:45:28Z","timestamp":1780965928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of avatrombopag-induced thrombocytosis in pediatric immune thrombocytopenia: an AI-based real-world study"],"prefix":"10.1007","volume":"105","author":[{"given":"Xi","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9333-8200","authenticated-orcid":false,"given":"Yongqiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4030-209X","authenticated-orcid":false,"given":"Runhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"2","key":"7086_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ped4.12305","volume":"6","author":"Working Group of Chinese Guideline for the Diagnosis and Treatment of Childhood Primary Immune Thrombocytopenia","year":"2021","unstructured":"Working Group of Chinese Guideline for the Diagnosis and Treatment of Childhood Primary Immune Thrombocytopenia, Subspecialty Group of Hematologic Diseases SoP, Chinese Medical Association, Editorial Board, Chinese Journal of Pediatrics (2021) Adapted guideline for the diagnosis and treatment of primary immune thrombocytopenia for Chinese children. Pediatr Investig 6(2):63\u201374. https:\/\/doi.org\/10.1002\/ped4.12305","journal-title":"Pediatr Investig"},{"issue":"22","key":"7086_CR2","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","volume":"3","author":"D Provan","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T et al (2019) Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 3(22):3780\u20133817. https:\/\/doi.org\/10.1182\/bloodadvances.2019000812","journal-title":"Blood Adv"},{"key":"7086_CR3","doi-asserted-by":"publisher","unstructured":"Grimes AB, Grace RF, Rose MJ, Shah SJ, Kaicker S, Bennett C et al A Phase 3 Study of eltrombopag vs. standard first-line management for newly diagnosed immune thrombocytopenia in children: trial in progress update. Blood 142 (1):1223\u20131223. https:\/\/doi.org\/10.1182\/blood-2023-17281","DOI":"10.1182\/blood-2023-17281"},{"issue":"7","key":"7086_CR4","doi-asserted-by":"publisher","first-page":"e494","DOI":"10.1016\/s2352-3026(25)00107-3","volume":"12","author":"RF Grace","year":"2025","unstructured":"Grace RF, Leblebisatan G, Aydinok Y, \u00dcnal \u015e, Grainger JD, Zhang J et al (2025) Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study. Lancet Haematol 12(7):e494\u2013e504. https:\/\/doi.org\/10.1016\/s2352-3026(25)00107-3","journal-title":"Lancet Haematol"},{"issue":"1","key":"7086_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.32143","volume":"73","author":"EM Harris","year":"2026","unstructured":"Harris EM, Montcrieff C, O\u2019Farrell C, Konde P, Lambert MP, Grimes AB et al (2026) Real-world use of avatrombopag in children and adolescents with immune thrombocytopenia. Pediatr Blood Cancer 73(1):e32143. https:\/\/doi.org\/10.1002\/pbc.32143","journal-title":"Pediatr Blood Cancer"},{"key":"7086_CR6","volume-title":"Avatrombopag (Doptelet): CADTH Reimbursement Recommendation: Indication: For the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment","author":"CADTH Reimbursement Reviews and Recommendations","year":"2024","unstructured":"CADTH Reimbursement Reviews and Recommendations (2024) Avatrombopag (Doptelet): CADTH Reimbursement Recommendation: Indication: For the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON)"},{"issue":"12","key":"7086_CR7","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1002\/ajh.27498","volume":"99","author":"C Pascual-Izquierdo","year":"2024","unstructured":"Pascual-Izquierdo C, S\u00e1nchez-Gonz\u00e1lez B, Canaro-Hirnyk MI, Garc\u00eda-Donas G, Menor-G\u00f3mez M, Gil-Fern\u00e1ndez JJ et al (2024) Avatrombopag in immune thrombocytopenia: a real-world study of the Spanish ITP Group (GEPTI). Am J Hematol 99(12):2328\u20132339. https:\/\/doi.org\/10.1002\/ajh.27498","journal-title":"Am J Hematol"},{"key":"7086_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19342","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhang A, Xu Z, Wang N, Zhang J, Meng J et al (2024) Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: a multicentre observational retrospective study in China. Br J Haematol. https:\/\/doi.org\/10.1111\/bjh.19342","journal-title":"Br J Haematol"},{"issue":"2","key":"7086_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ajh.27080","volume":"99","author":"ZM Virk","year":"2024","unstructured":"Virk ZM, Leaf RK, Kuter DJ, Goodarzi K, Connell NT, Connors JM et al (2024) Avatrombopag for adults with early versus chronic immune thrombocytopenia. Am J Hematol 99(2):155\u2013162. https:\/\/doi.org\/10.1002\/ajh.27080","journal-title":"Am J Hematol"},{"issue":"1","key":"7086_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62129-5","volume":"14","author":"H Zhu","year":"2024","unstructured":"Zhu H, Wu M (2024) Data mining and safety analysis of avatrombopag: a retrospective pharmacovigilance study based on the US Food and Drug Administration\u2019s adverse event reporting system. Sci Rep 14(1):11262. https:\/\/doi.org\/10.1038\/s41598-024-62129-5","journal-title":"Sci Rep"},{"key":"7086_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2025.103902","volume":"47","author":"A Turun\u00e7","year":"2025","unstructured":"Turun\u00e7 A, G\u00fcven\u00e7 B (2025) A case of thrombocytosis and hemothorax in a patient with ITP following romiplostim use. Hematol Transfus Cell Ther 47:103902. https:\/\/doi.org\/10.1016\/j.htct.2025.103902","journal-title":"Hematol Transfus Cell Ther"},{"issue":"3","key":"7086_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/bjh.15573","volume":"183","author":"W Jurczak","year":"2018","unstructured":"Jurczak W, Chojnowski K, Mayer J, Krawczyk K, Jamieson BD, Tian W et al (2018) Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia. Br J Haematol 183(3):479\u2013490. https:\/\/doi.org\/10.1111\/bjh.15573","journal-title":"Br J Haematol"},{"issue":"6","key":"7086_CR13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1080\/09537104.2020.1768523","volume":"31","author":"A Amgalan","year":"2020","unstructured":"Amgalan A, Othman M (2020) Hemostatic laboratory derangements in COVID-19 with a focus on platelet count. Platelets 31(6):740\u2013745. https:\/\/doi.org\/10.1080\/09537104.2020.1768523","journal-title":"Platelets"},{"issue":"3","key":"7086_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.yexmp.2007.08.005","volume":"83","author":"RV Mandal","year":"2007","unstructured":"Mandal RV, Mark EJ, Kradin RL (2007) Megakaryocytes and platelet homeostasis in diffuse alveolar damage. Exp Mol Pathol 83(3):327\u2013331. https:\/\/doi.org\/10.1016\/j.yexmp.2007.08.005","journal-title":"Exp Mol Pathol"},{"issue":"Supplement 1","key":"7086_CR15","doi-asserted-by":"publisher","first-page":"8410","DOI":"10.1182\/blood-2022-165239","volume":"140","author":"L Sun","year":"2022","unstructured":"Sun L, Qin P, Xu R, Wang J, Zhao H, Wang Y et al (2022) Eltrombopag plus diacerein versus eltrombopag in adult primary immune thrombocytopenia: interim analysis of a multicenter, randomized, controlled, phase 2 trial. Blood 140(Supplement 1):8410\u20138411. https:\/\/doi.org\/10.1182\/blood-2022-165239","journal-title":"Blood"},{"issue":"10","key":"7086_CR16","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/jcpt.13701","volume":"47","author":"JJ Jiang","year":"2022","unstructured":"Jiang JJ, Zhao B, Li J (2022) Does eltrombopag lead to thrombotic events? A pharmacovigilance study of the FDA adverse event reporting system. J Clin Pharm Ther 47(10):1556\u20131562. https:\/\/doi.org\/10.1111\/jcpt.13701","journal-title":"J Clin Pharm Ther"},{"issue":"10270","key":"7086_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s0140-6736(20)32519-8","volume":"397","author":"F D'Ascenzo","year":"2021","unstructured":"D\u2019Ascenzo F, De Filippo O, Gallone G, Mittone G, Deriu MA, Iannaccone M et al (2021) Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets. Lancet 397(10270):199\u2013207. https:\/\/doi.org\/10.1016\/s0140-6736(20)32519-8","journal-title":"Lancet"},{"key":"7086_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002545","author":"SP Heilbroner","year":"2021","unstructured":"Heilbroner SP, Few R, Mueller J, Chalwa J, Charest F, Suryadevara S et al (2021) Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-002545","journal-title":"J Immunother Cancer"},{"key":"7086_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.726229","volume":"12","author":"X He","year":"2021","unstructured":"He X, Yao P, Li M, Liang H, Liu Y, Du S et al (2021) A risk scoring model for high-dose methotrexate-induced liver injury in children with acute lymphoblastic leukemia based on gene polymorphism study. Front Pharmacol 12:726229. https:\/\/doi.org\/10.3389\/fphar.2021.726229","journal-title":"Front Pharmacol"},{"issue":"2","key":"7086_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ped4.12305","volume":"6","author":"Working Group of Chinese Guideline for the Diagnosis and Treatment of Childhood Primary Immune Thrombocytopenia; Subspecialty Group of Hematologic Diseases SoP","year":"2021","unstructured":"Working Group of Chinese Guideline for the Diagnosis and Treatment of Childhood Primary Immune Thrombocytopenia; Subspecialty Group of Hematologic Diseases SoP Chinese Medical Association Editorial Board, Chinese Journal of Pediatrics. Adapted guideline for the diagnosis and treatment of primary immune thrombocytopenia for Chinese children (2021). Pediatr Invest 6 (2):63\u201374. https:\/\/doi.org\/10.1002\/ped4.12305","journal-title":"Pediatr Invest"},{"key":"7086_CR21","unstructured":"Gorishniy Y, Rubachev I, Khrulkov V, Babenko A (2021) Revisiting deep learning models for tabular data. Paper presented at the proceedings of the 35th international conference on neural information processing systems"},{"key":"7086_CR22","doi-asserted-by":"publisher","unstructured":"Hollmann N, M\u00fcller S, Purucker L, Krishnakumar A, K\u00f6rfer M, Hoo SB et al Accurate predictions on small data with a tabular foundation model. Nature 637 (8045):319\u2013326. https:\/\/doi.org\/10.1038\/s41586-024-08328-6","DOI":"10.1038\/s41586-024-08328-6"},{"key":"7086_CR23","doi-asserted-by":"publisher","unstructured":"Wydma\u0144ski W, Bulenok O, \u015amieja M (2023) 2023 HyperTab: Hypernetwork approach for deep learning on small tabular datasets. In: 2023 IEEE 10th international conference on data science and advanced analytics (DSAA), 9\u201313 Oct. pp 1\u20139. https:\/\/doi.org\/10.1109\/DSAA60987.2023.10302504","DOI":"10.1109\/DSAA60987.2023.10302504"},{"key":"7086_CR24","doi-asserted-by":"publisher","unstructured":"Cheng X, Wang Z, Dong S, Ma J, Meng J, Wang X et al Outcomes of switching to avatrombopag following treatment failure with eltrombopag in paediatric immune thrombocytopenia: A real-world study in China. Br J Haematol 202 (3):636\u2013644. https:\/\/doi.org\/10.1111\/bjh.18864","DOI":"10.1111\/bjh.18864"},{"key":"7086_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/10760296221106779","volume":"28","author":"W Wang","year":"2022","unstructured":"Wang W, Tao S, Zhang X, Wang W, Xu Y, Liang W (2022) The value of combined detection of megakaryocyte and platelet parameters for the diagnosis of Primary Immune Thrombocytopenia. Clin Appl Thromb Hemost 28:10760296221106779. https:\/\/doi.org\/10.1177\/10760296221106779","journal-title":"Clin Appl Thromb Hemost"},{"key":"7086_CR26","doi-asserted-by":"publisher","unstructured":"Fattizzo B, Pasquale R, Carpenedo M, Cantoni S, Auteri G, Gramegna D et al Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogs. Haematologica 104 (10):e470\u2013e473. https:\/\/doi.org\/10.3324\/haematol.2019.216804","DOI":"10.3324\/haematol.2019.216804"},{"key":"7086_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042163","author":"A Mititelu","year":"2024","unstructured":"Mititelu A, Onis\u00e2i MC, Ro\u0219ca A, Vl\u0103d\u0103reanu AM (2024) Current understanding of Immune Thrombocytopenia: a review of pathogenesis and treatment options. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25042163","journal-title":"Int J Mol Sci"},{"key":"7086_CR28","doi-asserted-by":"publisher","unstructured":"Heitink-Poll\u00e9 KM, Nijsten J, Boonacker CW, de Haas M, Bruin MC Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis. Blood 124 (22):3295\u20133307. https:\/\/doi.org\/10.1182\/blood-2014-04-570127","DOI":"10.1182\/blood-2014-04-570127"},{"key":"7086_CR29","doi-asserted-by":"publisher","unstructured":"Zhou H, Xu M, Qin P, Zhang HY, Yuan CL, Zhao HG et al A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP. Blood 125 (10):1541\u20131547. https:\/\/doi.org\/10.1182\/blood-2014-06-581868","DOI":"10.1182\/blood-2014-06-581868"},{"key":"7086_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-026-00674-7","author":"Y Wang","year":"2026","unstructured":"Wang Y, Ai D, Wang S, Li Z, Li G, Zhu Y et al (2026) Machine learning estimation of FVIII pharmacokinetic parameters in Chinese children with severe hemophilia a. NPJ systems biology and applications. https:\/\/doi.org\/10.1038\/s41540-026-00674-7","journal-title":"NPJ systems biology and applications"},{"issue":"2","key":"7086_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2025.102702","volume":"9","author":"L Fu","year":"2025","unstructured":"Fu L, Lin X, Chen Z, Wang Z, Liu Y, Wang L et al (2025) Stepwise response-guided treatment protocol superior to thrombopoietin receptor agonist-based second-line therapy for severe persistent\/chronic immune thrombocytopenia: a multicenter prospective study from China. Research and practice in thrombosis and haemostasis 9(2):102702. https:\/\/doi.org\/10.1016\/j.rpth.2025.102702","journal-title":"Research and practice in thrombosis and haemostasis"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07086-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:02:19Z","timestamp":1783976539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07086-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["7086"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07086-x","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Beijing Children\u2019s Hospital approved the study ([2024]-Y-098-D). The study followed the principles outlined in the Declaration of Helsinki to ensure that written information was provided with the consent of all enrolled patients and their legally authorized guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}